GlaxoSmithKline starts search for new directors
November 7th, 2011 // 1:27 pm @ jmpickett
Ms Mann, founder of MWM Consulting, has already begun the search for up to two new non-executive directors to replace incumbents who are likely to retire at next May’s annual general meeting.
The search is understood to be part of a wider process to revive GSK’s 15-strong board, which includes 12 non-executive directors.
It is thought likely that Sir Crispin Davis, the former chief executive of Reed Elsevier, Larry Culp, chief executive of US conglomerate Danaher, and Sir Robert Wilson, the BG Group chairman, could be willing to step down at next year’s annual meeting.
All three men have sat on the board since June 2003. But it is unlikely all three would leave at once.
Other long-standing members include Sir Deryck Maughan, the former Salomon Brothers banker, who has been in place since 2004.
